FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2023267145> ?p ?o ?g. }

• W2023267145 endingPage "774" @default.
• W2023267145 startingPage "770" @default.
• W2023267145 abstract "Prothrombin complex concentrates (PCCs) offer a means for the rapid reversal of warfarin, particularly in the setting of life-threatening bleeding. We evaluated the effectiveness and safety of a PCC-based protocol in patients with warfarin-associated intracerebral hemorrhage (ICH), subdural hematoma (SDH), or subarachnoid hemorrhage (SAH). This was a retrospective case-series review of patients treated with an institution-approved warfarin reversal protocol. Patients with intracranial hemorrhage and known warfarin use with an international normalized ratio (INR) > 1.4 received fresh frozen plasma (FFP), vitamin K (phytonadione), and weight-based, 3-factor PCC (Profilnine® SD) dose based on the initial INR. Demographic and clinical information, the degree of and time to INR normalization, and adverse events were recorded. The thirty study patients included 19 with primary ICH, 7 with SDH, and 4 with SAH. The mean age was 72.8 (±11) years, including 11 (37%) patients ≥80 years old. The median presenting INR was 2.3 (IQR 2–3.3) and post-treatment INR was 1.4 (IQR 1.3–1.5, Z score 6.4, p < 0.001). Median time from PCC administration to the first follow up INR was 95 (IQR 50–140) min. No patient's INR increased by more than 0.3 over 72 h. Nine patients (30%) underwent neurosurgical procedures after PCC administration and no procedure-related bleeding complication was noted. Adverse events included 3 instances of early hematoma expansion, one ischemic stroke in a patient with endocarditis on post-PCC day 1, one pulmonary embolism 5 weeks after PCC treatment, and one coronary in-stent thrombosis 60 days after PCC treatment. 6 patients died prior to hospital discharge of anticipated complications of their initial event, and none from identifiable thrombotic complications of PCC. A 3-factor PCC preparation (Profilnine® SD), administered with FFP and vitamin K to patients with acute warfarin-associated intracranial bleeding is a reasonable approach to urgent warfarin reversal. However, randomized, prospective trials are needed to verify the safety and clinical effectiveness of PCC administration in this population." @default.
• W2023267145 created "2016-06-24" @default.
• W2023267145 creator A5002082733 @default.
• W2023267145 creator A5011195380 @default.
• W2023267145 creator A5045566906 @default.
• W2023267145 creator A5049615448 @default.
• W2023267145 creator A5060267238 @default.
• W2023267145 creator A5068740432 @default.
• W2023267145 creator A5084123774 @default.
• W2023267145 date "2013-06-01" @default.
• W2023267145 modified "2023-09-27" @default.
• W2023267145 title "Prothrombin complex concentrates to reverse warfarin-induced coagulopathy in patients with intracranial bleeding" @default.
• W2023267145 cites W104784625 @default.
• W2023267145 cites W1511722589 @default.
• W2023267145 cites W1979888396 @default.
• W2023267145 cites W1980595649 @default.
• W2023267145 cites W1986546417 @default.
• W2023267145 cites W2000180054 @default.
• W2023267145 cites W2014312811 @default.
• W2023267145 cites W2015052105 @default.
• W2023267145 cites W2017026770 @default.
• W2023267145 cites W2017233069 @default.
• W2023267145 cites W2020689733 @default.
• W2023267145 cites W2028568079 @default.
• W2023267145 cites W2031759462 @default.
• W2023267145 cites W2045644486 @default.
• W2023267145 cites W2058128077 @default.
• W2023267145 cites W2068476516 @default.
• W2023267145 cites W2071399101 @default.
• W2023267145 cites W2079197199 @default.
• W2023267145 cites W2110167268 @default.
• W2023267145 cites W2118340301 @default.
• W2023267145 cites W2124142208 @default.
• W2023267145 cites W2138238488 @default.
• W2023267145 cites W2143829405 @default.
• W2023267145 cites W2144129764 @default.
• W2023267145 cites W2147549352 @default.
• W2023267145 cites W2152647843 @default.
• W2023267145 cites W2158203908 @default.
• W2023267145 doi "https://doi.org/10.1016/j.clineuro.2012.07.006" @default.
• W2023267145 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/22835715" @default.
• W2023267145 hasPublicationYear "2013" @default.
• W2023267145 type Work @default.
• W2023267145 sameAs 2023267145 @default.
• W2023267145 citedByCount "44" @default.
• W2023267145 countsByYear W20232671452013 @default.
• W2023267145 countsByYear W20232671452014 @default.
• W2023267145 countsByYear W20232671452015 @default.
• W2023267145 countsByYear W20232671452016 @default.
• W2023267145 countsByYear W20232671452017 @default.
• W2023267145 countsByYear W20232671452018 @default.
• W2023267145 countsByYear W20232671452019 @default.
• W2023267145 countsByYear W20232671452020 @default.
• W2023267145 countsByYear W20232671452022 @default.
• W2023267145 countsByYear W20232671452023 @default.
• W2023267145 crossrefType "journal-article" @default.
• W2023267145 hasAuthorship W2023267145A5002082733 @default.
• W2023267145 hasAuthorship W2023267145A5011195380 @default.
• W2023267145 hasAuthorship W2023267145A5045566906 @default.
• W2023267145 hasAuthorship W2023267145A5049615448 @default.
• W2023267145 hasAuthorship W2023267145A5060267238 @default.
• W2023267145 hasAuthorship W2023267145A5068740432 @default.
• W2023267145 hasAuthorship W2023267145A5084123774 @default.
• W2023267145 hasConcept C126322002 @default.
• W2023267145 hasConcept C141071460 @default.
• W2023267145 hasConcept C165455791 @default.
• W2023267145 hasConcept C197934379 @default.
• W2023267145 hasConcept C2776265017 @default.
• W2023267145 hasConcept C2776301958 @default.
• W2023267145 hasConcept C2777091921 @default.
• W2023267145 hasConcept C2777094939 @default.
• W2023267145 hasConcept C2777736543 @default.
• W2023267145 hasConcept C2779161974 @default.
• W2023267145 hasConcept C2779662492 @default.
• W2023267145 hasConcept C2779936836 @default.
• W2023267145 hasConcept C2780434524 @default.
• W2023267145 hasConcept C42219234 @default.
• W2023267145 hasConcept C66112548 @default.
• W2023267145 hasConcept C71924100 @default.
• W2023267145 hasConcept C89560881 @default.
• W2023267145 hasConceptScore W2023267145C126322002 @default.
• W2023267145 hasConceptScore W2023267145C141071460 @default.
• W2023267145 hasConceptScore W2023267145C165455791 @default.
• W2023267145 hasConceptScore W2023267145C197934379 @default.
• W2023267145 hasConceptScore W2023267145C2776265017 @default.
• W2023267145 hasConceptScore W2023267145C2776301958 @default.
• W2023267145 hasConceptScore W2023267145C2777091921 @default.
• W2023267145 hasConceptScore W2023267145C2777094939 @default.
• W2023267145 hasConceptScore W2023267145C2777736543 @default.
• W2023267145 hasConceptScore W2023267145C2779161974 @default.
• W2023267145 hasConceptScore W2023267145C2779662492 @default.
• W2023267145 hasConceptScore W2023267145C2779936836 @default.
• W2023267145 hasConceptScore W2023267145C2780434524 @default.
• W2023267145 hasConceptScore W2023267145C42219234 @default.
• W2023267145 hasConceptScore W2023267145C66112548 @default.
• W2023267145 hasConceptScore W2023267145C71924100 @default.
• W2023267145 hasConceptScore W2023267145C89560881 @default.
• W2023267145 hasIssue "6" @default.

• next